FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2893734878> ?p ?o ?g. }

• W2893734878 endingPage "e324" @default.
• W2893734878 startingPage "e315" @default.
• W2893734878 abstract "Background Dutch guidelines advise extended anticoagulant treatment with direct oral anticoagulants or vitamin K antagonists for patients with idiopathic venous thromboembolism (VTE) who do not have high bleeding risk. Objectives The aim of this study was to analyze the economic effects of extended treatment of apixaban in the Netherlands, based on an updated and adapted previously published model. Methods We performed a cost-effectiveness analysis simulating a population of 1,000 VTE patients. The base-case analysis compared extended apixaban treatment to no treatment after the first 6 months. Five additional scenarios were conducted to evaluate the effect of different bleeding risks and health care payers' perspective. The primary outcome of the model is the incremental cost-effectiveness ratio (ICER) in costs (€) per quality-adjusted life-year (QALY), with one QALY defined as 1 year in perfect health. To account for any influence of the uncertainties in the model, probabilistic and univariate sensitivity analyses were conducted. The treatment was considered cost-effective with an ICER less than €20,000/QALY, which is the most commonly used willingness-to-pay (WTP) threshold for preventive drugs in the Netherlands. Results The model showed a reduction in recurrent VTE and no increase in major bleeding events for extended treatment in all scenarios. The base-case analysis showed an ICER of €9,653/QALY. The probability of being cost-effective for apixaban in the base-case was 70.0% and 91.4% at a WTP threshold of €20,000/QALY and €50,000/QALY, respectively. Conclusion Extended treatment with apixaban is cost-effective for the prevention of recurrent VTE in Dutch patients." @default.
• W2893734878 created "2018-10-05" @default.
• W2893734878 creator A5003738592 @default.
• W2893734878 creator A5007368612 @default.
• W2893734878 creator A5016565734 @default.
• W2893734878 creator A5026613773 @default.
• W2893734878 creator A5037895760 @default.
• W2893734878 creator A5085077159 @default.
• W2893734878 creator A5088753423 @default.
• W2893734878 date "2018-07-01" @default.
• W2893734878 modified "2023-09-27" @default.
• W2893734878 title "Extended Treatment with Apixaban for Venous Thromboembolism Prevention in the Netherlands: Clinical and Economic Effects" @default.
• W2893734878 cites W1565146166 @default.
• W2893734878 cites W1887749119 @default.
• W2893734878 cites W2002003793 @default.
• W2893734878 cites W2011127570 @default.
• W2893734878 cites W2023683634 @default.
• W2893734878 cites W2037153059 @default.
• W2893734878 cites W2067254496 @default.
• W2893734878 cites W2078329863 @default.
• W2893734878 cites W2080839482 @default.
• W2893734878 cites W2102778065 @default.
• W2893734878 cites W2115228767 @default.
• W2893734878 cites W2139785591 @default.
• W2893734878 cites W2146289187 @default.
• W2893734878 cites W2166402206 @default.
• W2893734878 cites W2225937646 @default.
• W2893734878 cites W2334353679 @default.
• W2893734878 cites W2346306684 @default.
• W2893734878 cites W2538602808 @default.
• W2893734878 cites W2581509534 @default.
• W2893734878 doi "https://doi.org/10.1055/s-0038-1672185" @default.
• W2893734878 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6524888" @default.
• W2893734878 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31249955" @default.
• W2893734878 hasPublicationYear "2018" @default.
• W2893734878 type Work @default.
• W2893734878 sameAs 2893734878 @default.
• W2893734878 citedByCount "3" @default.
• W2893734878 countsByYear W28937348782019 @default.
• W2893734878 countsByYear W28937348782020 @default.
• W2893734878 countsByYear W28937348782022 @default.
• W2893734878 crossrefType "journal-article" @default.
• W2893734878 hasAuthorship W2893734878A5003738592 @default.
• W2893734878 hasAuthorship W2893734878A5007368612 @default.
• W2893734878 hasAuthorship W2893734878A5016565734 @default.
• W2893734878 hasAuthorship W2893734878A5026613773 @default.
• W2893734878 hasAuthorship W2893734878A5037895760 @default.
• W2893734878 hasAuthorship W2893734878A5085077159 @default.
• W2893734878 hasAuthorship W2893734878A5088753423 @default.
• W2893734878 hasBestOaLocation W28937348781 @default.
• W2893734878 hasConcept C112930515 @default.
• W2893734878 hasConcept C126322002 @default.
• W2893734878 hasConcept C177713679 @default.
• W2893734878 hasConcept C2776301958 @default.
• W2893734878 hasConcept C2778661090 @default.
• W2893734878 hasConcept C2779161974 @default.
• W2893734878 hasConcept C2780638905 @default.
• W2893734878 hasConcept C2908647359 @default.
• W2893734878 hasConcept C3019080777 @default.
• W2893734878 hasConcept C515549039 @default.
• W2893734878 hasConcept C64332521 @default.
• W2893734878 hasConcept C71924100 @default.
• W2893734878 hasConcept C99454951 @default.
• W2893734878 hasConceptScore W2893734878C112930515 @default.
• W2893734878 hasConceptScore W2893734878C126322002 @default.
• W2893734878 hasConceptScore W2893734878C177713679 @default.
• W2893734878 hasConceptScore W2893734878C2776301958 @default.
• W2893734878 hasConceptScore W2893734878C2778661090 @default.
• W2893734878 hasConceptScore W2893734878C2779161974 @default.
• W2893734878 hasConceptScore W2893734878C2780638905 @default.
• W2893734878 hasConceptScore W2893734878C2908647359 @default.
• W2893734878 hasConceptScore W2893734878C3019080777 @default.
• W2893734878 hasConceptScore W2893734878C515549039 @default.
• W2893734878 hasConceptScore W2893734878C64332521 @default.
• W2893734878 hasConceptScore W2893734878C71924100 @default.
• W2893734878 hasConceptScore W2893734878C99454951 @default.
• W2893734878 hasIssue "03" @default.
• W2893734878 hasLocation W28937348781 @default.
• W2893734878 hasLocation W28937348782 @default.
• W2893734878 hasLocation W28937348783 @default.
• W2893734878 hasLocation W28937348784 @default.
• W2893734878 hasLocation W28937348785 @default.
• W2893734878 hasOpenAccess W2893734878 @default.
• W2893734878 hasPrimaryLocation W28937348781 @default.
• W2893734878 hasRelatedWork W2092414428 @default.
• W2893734878 hasRelatedWork W2176270072 @default.
• W2893734878 hasRelatedWork W2471581890 @default.
• W2893734878 hasRelatedWork W2599933528 @default.
• W2893734878 hasRelatedWork W2766249202 @default.
• W2893734878 hasRelatedWork W2893734878 @default.
• W2893734878 hasRelatedWork W2899174159 @default.
• W2893734878 hasRelatedWork W2903216643 @default.
• W2893734878 hasRelatedWork W3084910069 @default.
• W2893734878 hasRelatedWork W4320496215 @default.
• W2893734878 hasVolume "02" @default.
• W2893734878 isParatext "false" @default.
• W2893734878 isRetracted "false" @default.
• W2893734878 magId "2893734878" @default.

• next